Heart Closure Devices Market Size And Forecast 2026–2030: Trends Driving Industry Expansion

Heart Closure Devices Market Report

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Heart Closure Devices Market Poised To Hit $5.42 Billion By 2030 With A 11.9% CAGR

The market for heart closure devices has expanded significantly in recent times. This market is projected to expand from $3.08 billion in 2025 to $3.46 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.2%. Several factors have contributed to its historical growth, including the increasing prevalence of congenital heart defects, the expansion of catheterization laboratories, the growing adoption of minimally invasive cardiac treatments, a rising awareness of structural heart conditions, and the availability of advanced imaging guidance.

The heart closure devices market size is projected for substantial growth in the upcoming years, with expectations to reach $5.42 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.9%. This anticipated expansion during the forecast period is fueled by an escalating demand for catheter-based cardiac therapies, increased investments in structural heart disease treatment, the establishment of more specialized cardiac centers, a heightened emphasis on minimizing surgical risks, and continuous technological advancements in the design of closure devices. Prominent trends observed in this period include the wider adoption of transcatheter heart closure procedures, a rising preference for minimally invasive cardiac devices, the expanded application of nitinol-based closure systems, the growth of structural heart intervention programs, and an intensified focus on ensuring procedural safety and efficacy.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=68570581&type=smp&name=Heart%20Closure%20Devices%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Heart Closure Devices Market Expansion Drivers: What’s Shaping Future Growth?

The rising occurrence of cardiovascular diseases (CVDs) is anticipated to propel the growth of the heart closure devices market going forward. This escalating incidence of CVDs stems from factors such as aging, unhealthy lifestyle choices, genetic predisposition, and the increasing prevalence of risk factors like hypertension, diabetes, and obesity. Heart closure devices play a crucial role in reducing complications from congenital heart defects by minimally invasively sealing abnormal openings in the heart, thereby enhancing blood flow and preventing further health issues. For instance, in May 2024, information from the Singapore Heart Foundation (SHF), a non-profit organization based in Singapore, revealed that the total number of deaths due to cardiovascular disease reached 26,885 in 2023. Additionally, ischemic heart disease led to 5,302 deaths, marking an increase from 5,290 deaths recorded in 2022. Thus, the escalating incidence of cardiovascular diseases (CVDs) is a key driver for the expansion of the heart closure devices market.

Heart Closure Devices Market Segment Landscape: Which Areas Lead Development?

The heart closure devices market covered in this report is segmented –

1) By Product: Atrial Septal Defect (ASD) Closure Devices, Ventricular Septal Defect (VSD) Closure Devices, Patent Foramen Ovale (PFO) Closure Devices, Left Atrial Appendage (LAA) Closure Devices, Other Products

2) By Material: Nitinol-Based Devices, Stainless Steel Devices, Other Materials

3) By Mode of Delivery: Transcatheter Delivery, Surgical Delivery

4) By End Use: Hospitals, Ambulatory Surgical Centers (ASCs), Cardiac Catheterization Laboratories, Other End Uses

Subsegments:

1) By Atrial Septal Defect (ASD) Closure Devices: Self-expanding Occluders, Balloon-expandable Occluders, Other ASD Closure Devices

2) By Ventricular Septal Defect (VSD) Closure Devices: Transcatheter VSD Closure Devices, Surgical VSD Closure Devices, Other VSD Closure Devices

3) By Patent Foramen Ovale (PFO) Closure Devices: Double-Disc Occluders, Single-Disc Occluders, Other PFO Closure Devices

4) By Left Atrial Appendage (LAA) Closure Devices: LAA Occluders, LAA Clip Systems, Other LAA Closure Devices

5) By Other Products: Septal Defect Closure Devices, Endovascular Closure Devices, Other Specialty Closure Devices

Heart Closure Devices Market Strategic Trends: What Defines The Next Growth Phase?

Major companies operating in the heart closure devices market are concentrating on technological advancements, such as creating low-profile, ergonomic surgical LAA devices featuring continuous closing force mechanisms. These innovations are designed to improve procedural precision, visibility, and ease of use for physicians, while simultaneously enhancing patient outcomes. Low-Profile Surgical LAA Devices enable secure and effective closure of the left atrial appendage, ensuring optimal tissue compression, simplified single-handed placement, and better access during minimally invasive procedures. For example, in August 2024, AtriCure, Inc., a US-based cardiac surgical solutions company, treated its first patient with the AtriClip FLEX-Mini device, which is currently the smallest-profile surgical LAA device available on the market. Building on the established AtriClip platform, this device incorporates a fully enclosed design with parallel beams for consistent closing force, offers improved visibility, and features an ergonomic handle for single-handed placement, thereby assisting physicians in providing precise, safe, and efficient LAA management for patients with atrial fibrillation.

Heart Closure Devices Market Competitive Landscape: Who Leads The Industry?

Major companies operating in the heart closure devices market are Abbott Laboratories, Medtronic plc, Boston Scientific Corp., Lepu Medical Technology Ltd., Terumo Corporation, Edwards Lifesciences, Teleflex Incorporated, Merit Medical Systems Inc., Cordis Corporation, AtriCure Inc., Lifetech Scientific Corp., Sahajanand Medical Technologies, W. L. Gore And Associates Inc., Occlutech GmbH, NMT Medical Inc., Sorin Group Italia S.p.A., Vivasure Medical Limited, B Braun Interventional Systems, HeartStitch Inc., MicroPort Scientific Corporation

View The Full Heart Closure Devices Market Report:

https://thebusinessresearchcompany.com/report/heart-closure-devices-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Heart Closure Devices Market Geographic Landscape: Which Region Dominates Industry Growth?

North America was the largest region in the heart closure devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart closure devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model